| Bioactivity | Acetyl-Amylin (8-37) (human) is a specific amylin antagonist[1]. |
| Invitro | Amylin has the potential to exert an autocrine or paracrine effect on islet insulin secretion[2]. |
| Name | Acetyl-Amylin (8-37) (human) |
| CAS | 178603-79-7 |
| Sequence | Ac-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 |
| Shortening | Ac-ATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2 |
| Formula | C140H218N42O46 |
| Molar Mass | 3225.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. M Hettiarachchi, et al. Rat amylin-(8-37) enhances insulin action and alters lipid metabolism in normal and insulin-resistant rats. Am J Physiol. 1997 Nov;273(5):E859-67. [2]. I Villa , et al. Effects of calcitonin gene-related peptide and amylin on human osteoblast-like cells proliferation. Eur J Pharmacol. 2000 Dec 15;409(3):273-8. |